Companies scramble to expand coronavirus vaccine supply

by

Pfizer and Moderna have been working to increase production and reporting success, but supply will fall short of global demand. Other vaccine companies are lagging on manufacturing.

View original article
Contributor: Carolyn Y. Johnson